Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 19966213)

1.

CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice.

Oracki SA, Tsantikos E, Quilici C, Light A, Schmidt T, Lew AM, Martin JE, Smith KG, Hibbs ML, Tarlinton DM.

J Immunol. 2010 Jan 15;184(2):757-63. doi: 10.4049/jimmunol.0804349. Epub 2009 Dec 4.

2.

Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.

Tsantikos E, Oracki SA, Quilici C, Anderson GP, Tarlinton DM, Hibbs ML.

J Immunol. 2010 Feb 1;184(3):1348-60. doi: 10.4049/jimmunol.0901878. Epub 2009 Dec 30.

3.

IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.

Gutierrez T, Mayeux JM, Ortega SB, Karandikar NJ, Li QZ, Rakheja D, Zhou XJ, Satterthwaite AB.

Eur J Immunol. 2013 Feb;43(2):382-93. doi: 10.1002/eji.201142095. Epub 2012 Dec 18.

4.

Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice.

Hua Z, Gross AJ, Lamagna C, Ramos-Hernández N, Scapini P, Ji M, Shao H, Lowell CA, Hou B, DeFranco AL.

J Immunol. 2014 Feb 1;192(3):875-85. doi: 10.4049/jimmunol.1300683. Epub 2013 Dec 30.

5.

Attenuation of phosphoinositide 3-kinase ╬┤ signaling restrains autoimmune disease.

Maxwell MJ, Tsantikos E, Kong AM, Vanhaesebroeck B, Tarlinton DM, Hibbs ML.

J Autoimmun. 2012 Jun;38(4):381-91. doi: 10.1016/j.jaut.2012.04.001. Epub 2012 Apr 25.

PMID:
22537464
6.

Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene.

Moon BG, Takaki S, Nishizumi H, Yamamoto T, Takatsu K.

Cell Immunol. 2004 Apr;228(2):110-8.

PMID:
15219462
7.

B cell-specific loss of Lyn kinase leads to autoimmunity.

Lamagna C, Hu Y, DeFranco AL, Lowell CA.

J Immunol. 2014 Feb 1;192(3):919-28. doi: 10.4049/jimmunol.1301979. Epub 2013 Dec 27.

8.

Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease.

Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR.

Cell. 1995 Oct 20;83(2):301-11.

9.

CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.

Mihara M, Tan I, Chuzhin Y, Reddy B, Budhai L, Holzer A, Gu Y, Davidson A.

J Clin Invest. 2000 Jul;106(1):91-101.

10.

A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.

Verhagen AM, Wallace ME, Goradia A, Jones SA, Croom HA, Metcalf D, Collinge JE, Maxwell MJ, Hibbs ML, Alexander WS, Hilton DJ, Kile BT, Starr R.

J Immunol. 2009 Feb 15;182(4):2020-9. doi: 10.4049/jimmunol.0803127.

11.

Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig.

Chu EB, Hobbs MV, Wilson CB, Romball CG, Linsley PS, Weigle WO.

J Immunol. 1996 Feb 1;156(3):1262-8.

PMID:
8558006
12.

Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.

Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T.

Immunity. 1995 Nov;3(5):549-60.

PMID:
7584145
13.

Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.

Takeshita H, Taniuchi I, Kato J, Watanabe T.

Int Immunol. 1998 Apr;10(4):435-44.

14.

Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity.

Hibbs ML, Harder KW, Armes J, Kountouri N, Quilici C, Casagranda F, Dunn AR, Tarlinton DM.

J Exp Med. 2002 Dec 16;196(12):1593-604.

15.

Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.

Tsantikos E, Maxwell MJ, Kountouri N, Harder KW, Tarlinton DM, Hibbs ML.

J Immunol. 2012 Aug 15;189(4):1726-36. doi: 10.4049/jimmunol.1103427. Epub 2012 Jul 13.

16.

MyD88-dependent autoimmune disease in Lyn-deficient mice.

Silver KL, Crockford TL, Bouriez-Jones T, Milling S, Lambe T, Cornall RJ.

Eur J Immunol. 2007 Oct;37(10):2734-43.

PMID:
17853409
17.

Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.

Whyburn LR, Halcomb KE, Contreras CM, Lowell CA, Witte ON, Satterthwaite AB.

J Immunol. 2003 Aug 15;171(4):1850-8.

19.

B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.

Scapini P, Lamagna C, Hu Y, Lee K, Tang Q, DeFranco AL, Lowell CA.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):E823-32. doi: 10.1073/pnas.1107913108. Epub 2011 Sep 12.

20.

Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.

Lau M, Tsantikos E, Maxwell MJ, Tarlinton DM, Anderson GP, Hibbs ML.

J Autoimmun. 2012 Dec;39(4):388-97. doi: 10.1016/j.jaut.2012.06.003. Epub 2012 Aug 4.

PMID:
22867713
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk